Clinical Characteristics of Patients
| . | IdCSA . | IdCSA + IdMTX . | P . |
|---|---|---|---|
| No. of patients | 28 | 32 | |
| Age (y) | |||
| Median (range) | 29 (14-43) | 30 (11-43) | NS-150 |
| Recipient gender | |||
| Male/female | 13/15 | 18/14 | NS-151 |
| Donor age (y) | |||
| Median (range) | 27 (15-47) | 30 (9-51) | NS-150 |
| Donor gender | |||
| Male/female | 16/12 | 14/18 | NS-150 |
| Disease status | |||
| CR1 | 23 | 26 | NS-151 |
| >CR1 | 5 | 6 | NS-151 |
| FAB classification | |||
| M1-M2 | 13 | 14 | |
| M3 | 7 | 6 | |
| M4-M5 | 7 | 11 | |
| M6 | 0 | 1 | |
| M7 | 1 | 0 | |
| Days from diagnosis to HSCT | |||
| Median (range) | 183 (108-356) | 173 (58-542) | NS-150 |
| No. of infused cells (×108/kg) | |||
| Median (range) | 3.4 (1.5-10) | 4.5 (1.3-11) | .09-150 |
| . | IdCSA . | IdCSA + IdMTX . | P . |
|---|---|---|---|
| No. of patients | 28 | 32 | |
| Age (y) | |||
| Median (range) | 29 (14-43) | 30 (11-43) | NS-150 |
| Recipient gender | |||
| Male/female | 13/15 | 18/14 | NS-151 |
| Donor age (y) | |||
| Median (range) | 27 (15-47) | 30 (9-51) | NS-150 |
| Donor gender | |||
| Male/female | 16/12 | 14/18 | NS-150 |
| Disease status | |||
| CR1 | 23 | 26 | NS-151 |
| >CR1 | 5 | 6 | NS-151 |
| FAB classification | |||
| M1-M2 | 13 | 14 | |
| M3 | 7 | 6 | |
| M4-M5 | 7 | 11 | |
| M6 | 0 | 1 | |
| M7 | 1 | 0 | |
| Days from diagnosis to HSCT | |||
| Median (range) | 183 (108-356) | 173 (58-542) | NS-150 |
| No. of infused cells (×108/kg) | |||
| Median (range) | 3.4 (1.5-10) | 4.5 (1.3-11) | .09-150 |